Dr Garon speaks with ecancertv at the Best of ASCO 2016 about targetable mutations in lung cancer.

With examples of BRAF and RET mutations, he discusses the clinical significance of sequencing data in achieving a patient's best possible responses to therapy.

For more on lung cancer sequencing, watch Dr Bruce Johnson speaking to ecancertv at WIN 2016.